Doç. Dr.Mehmet Taşdemir

  • İlgi Alanları
  • Böbrek yetmezliği
  • Diyaliz
  • Böbrek nakli
  • İdrar yolu enfeksiyonları
  • İdrar kaçırma
  • Nefrotik sendrom
  • Glomerülonefritler
  • Hipertansiyon

Eğitim ve Uzmanlık
Yüksek Lisans: Tıp, Trakya Üniversitesi, 1992-1998
Tıpta Uzmanlık: Çocuk Sağlığı ve Hastalıkları, Şişli Etfal Eğitim ve Araştırma Hastanesi, İstanbul, 2004-2009
Yan Dal Uzmanlık: Çocuk Nefrolojisi, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İstanbul, 2009-2013
Çocuk Nefrolojisi Doçentliği, 2019
FESPN (Fellow of European Society for Paediatric Nephrology ünvanı, 2020’de Avrupa Çocuk Nefrolojisi Birliği tarafından verildi)

Deneyim
Liv Hospital Ulus, İstanbul, 5/2021
Koç Üniversitesi Hastanesi, İstanbul, Çocuk Nefrolojisi Doçenti, 2019-2021
Koç Üniversitesi Hastanesi, İstanbul, Çocuk Nefrolojisi Uzmanı, 2015-2019
Boston Children's Hospital, Harvard Medical School, USA, Boston, Massachusetts, Clinical Observer, 2015
Sağlık Bilimleri Üniversitesi, Bağcılar Eğitim ve Araştırma Hastanesi, İstanbul, Çocuk Nefrolojisi Uzmanı, İstanbul, 2013-2015
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Çocuk Nefrolojisi Yan Dal Asistanı, 2009-2013
Şişli Etfal Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları Asistanı, İstanbul, 2004-2009
Genel pratisyenlik, 1998-2004

Mesleki Üyelikler
International Pediatric Nephrology Association (IPNA), 2013-günümüz
European Society of Paediatric Nephrology (ESPN), 2013- günümüz
European Renal Association-European Dialysis and Transplant Association (ERA-EDTA), 2013- günümüz
Türk Nefroloji Derneği, 2013- günümüz
Çocuk Nefroloji Derneği, 2013- günümüz
Türk Pediatri Kurumu, 2010-2013- günümüz
Türk Tabipleri Birliği, 1998-2013- günümüz

  1. Önal B, Kırlı EA, Canpolat N, Taşdemir M, Gürbüz A, Özman O, Sever L, Bilge I, Çalışkan S. Different approaches among physicians to treat pediatric stone disease: a survey-based study. Arch Argent Pediatr. 2021 Apr;119(2):83-90. Spanish, English. doi: 10.5546/aap.2021.eng.83. PMID: 33749193.
  2. Taşdemir M, Canpolat N, Yildiz N, Özçelik G, Benzer M, Saygılı SK, Özkayın EN, Türkkan ÖN, Balat A, Candan C, Çelakıl M, Yavuz S, Akıncı N, Göknar N, Akgün C, Tülpar S, Alpay H, Sever FL, Bilge İ. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study. Turk J Med Sci. 2021 Feb 14. doi: 10.3906/sag-2012-297. Epub ahead of print. PMID: 33581711.
  3. Taşdemir M, Erginöz E, Gayret ÖB, Bilge I. Ambulatory arterial stiffness index is increased in obese children. Turk J Pediatr. 2020;62(2):259-266. doi: 10.24953/turkjped.2020.02.012. PMID: 32419418.
  4. Pınarbaşı AS, Dursun I, Gokce I, Çomak E, Saygılı S, Bayram MT, Donmez O, Melek E, Tekcan D, Çiçek N, Yılmaz D, Tabel Y, Yıldırım ZY, Bahat E, Koyun M, Soylu A, Canpolat N, Aksu B, Çelakıl ME, Taşdemir M, Benzer M, Özçelik G, Bakkaloğlu SA, Düşünsel R. Predictors of poor kidney outcome in children with C3 glomerulopathy. Pediatr Nephrol. 2020 Oct 31. doi: 10.1007/s00467-020-04799-7. Epub ahead of print. PMID: 33130981.
  5. Özler O, Mutlu GY, Taşdemir M, Avcı Ş, Bilge I, Hatun Ş. An 8-month-old infant with hypercalcemia and hyperphosphatemia-Answers. Pediatr Nephrol. 2021 Mar;36(3):563-566. doi: 10.1007/s00467-020-04666-5. Epub 2020 Jun 25. PMID: 32588225.
  6. Özler O, Mutlu GY, Taşdemir M, Avcı Ş, Bilge I, Hatun Ş. An 8-month-old infant with hypercalcemia and hyperphosphatemia: Questions. Pediatr Nephrol. 2021 Mar;36(3):561-562. doi: 10.1007/s00467-020-04656-7. Epub 2020 Jun 25. PMID: 32588220.
  7. Özen MA, Taşdemir M, Aygün MS, Necef I, Aydın E, Bilge I, Eroğlu E. Is there a unique symptom in lower urinary tract dysfunction in children? Low Urin Tract Symptoms. 2020 Nov 2. doi: 10.1111/luts.12363. Epub ahead of print. PMID: 33137854.
  8. Mutlu GY, Taşdemir M, Kızılkan NU, Güran T, Hatun Ş, Kayserili H, Bilge I. 2019. A rare cause of chronic hyponatremia in an infant: Questions. Pediatr Nephrol, doi: 10.1007/s00467-019-04335-2
  9. Mutlu GY, Taşdemir M, Kızılkan NU, Güran T, Hatun Ş, Kayserili H, Bilge I. 2019. A rare cause of chronic hyponatremia in an infant: Answers. Pediatr Nephrol, doi: 10.1007/s00467-019-04337-0
  10. Bilge I, Taşdemir M. Periton diyalizinin dünyada ve Türkiye’de demografik özellikleri. Ekim M, editör. Çocuklarda Kronik Periton Diyalizi. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.10-6.
  11. Taşdemir M, Yılmaz S, Baba ZF, Bilge I. Comments on the letter of Galland et al. on “A rare cause of AA amyloidosis and end-stage kidney failure” Pediatr Nephrol. 2019, doi: 10.1007/s00467-019-04277-9
  12. Sönmez HE, Canpolat N, Ağbaş A, Taşdemir M, Ekmekçi ÖB, Alikaşifoğlu M, Sever L, Çalışkan S. The Relationship between the Waist Circumference and Increased Carotid Intima Thickness in Obese Children. Child Obes. 2019 Oct;15(7):468-475. doi: 10.1089/chi.2019.0022. Epub 2019 Jun 27. PMID: 31246513.
  13. Özen MA, Mutluer T, Necef I, Shabsog M, Taşdemir M, Bilge I, Eroğlu E. The overlooked association between lower urinary tract dysfunction and psychiatric disorders: a short screening test for clinical practice. J Pediatr Urol. 2109, doi: 10.1016/j.jpurol.2019.03.025.
  14. Bilge I, Taşdemir M. Prenatal Tanılı Kistik Böbrek Hastalıkları. Ander AH, Ziylan HO, Oktar T,editörler. Üriner Sistem Anomalilerinin Prenatal Tanısı ve Postnatal Takibi - II. 1. Baskı. Ankara: Türkiye Klinikleri; 2019. p.20-8
  15. Taşdemir M, Yılmaz S, Baba ZF, Bilge I. A rare cause of AA amyloidosis and end-stage kidney failure: Questions. Pediatr Nephrol. 2018, doi: 10.1007/s00467-018-4152-7.
  16. Taşdemir M, Yılmaz S, Baba ZF, Bilge I. A rare cause of AA amyloidosis and end-stage kidney failure: Answers. Pediatr Nephrol. 2018, doi: 10.1007/s00467-018-4153-6.
  17. Yurt A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S. Outbreak of Shiga Toxin-producing Escherichia coli-associated Hemolytic Uremic Syndrome in Istanbul in 2015: Outcome and Experience with Eculizumab. Pediatr Nephrol. 2018, doi: 10.1007/s00467-0184033-0.
  18. Bostan Gayret Ö, Taşdemir M, Erol M, Nacaroğlu HT, Zengi O, Yiğit Ö Are there any new reliable markers to detect renal injury in obese children? Biomarkers in obese children. Renal Failure. 2018, 40(1), 416-422., doi: 10.1080/0886022X.2018.1489284
  19. Ozen MA, Tasdemir M, Gündoğdu G, Bilge I, Büyükünal C, Eroğlu E. Does Voiding Cystourethrogram Exclude Posterior Urethral Valves in Late Presenting Cases? J Ped Surgery. 2018, doi: 10.1055/s-00381672146.
  20. Bakkaloğlu SA, Kandur Y, Akcaboy M, Serdaroğlu E, Noyan A, Parmaksız G, Bayazıt AK, Sever L, Taşdemir M, Özlü SG, Özçelik G, Dursun İ, Alparslan C. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients. Pediatric Nephrol. 2018, 33(11), doi: 10.1007/s00467-018-4013-4,
  21. Canpolat N, Sever L, Ağbaş A, Taşdemir M, Oruç Ç, Ekmekci OB, Caliskan S, Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.  Pediatr Nephrol. 2018. https://doi.org/10.1007/s00467-018-4002-7
  22. Taşdemir M, Kaya H, Taşdemir ZA. Does pyuria always suggest urinary tract infection with common microorganisms? Questions. Pediatr Nephrol. 2018 Apr;33(4):611-613. doi: 10.1007/s00467-017-3727-z.
  23. Taşdemir M, Kaya H, Taşdemir ZA. Does pyuria always suggest urinary tract infection with common microorganisms? Answers. Pediatr Nephrol. 2018 Apr;33(4):615-617. doi: 10.1007/s00467-017-3734-0.
  24. Taşdemir M, Fuçucuoğlu D, Küçük SH, Erol M, Yiğit Ö, Bilge I. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis. Clin Exp Nephrol. 2018 Feb;22(1):133-141. doi: 10.1007/s10157-017-1436-3.
  25. Özen MA, Gündoğdu G, Taşdemir M, Eroğlu E. Complication of newborn circumcision: Meatal stenosis or meatal web? J Pediatr Urol. 2017 Dec;13(6):617.e1-617.e4. doi: 10.1016/j.jpurol.2017.05.007.
  26. Rosti RO, Sotak BN, Bielas SL, Bhat G, Silhavy JL, Aslanger AD, Altunoglu U, Bilge I, Tasdemir M, Yzaguirrem AD, Musaev D, Infante S, Thuong W, Marin-Valencia I, Nelson SF, Kayserili H, Gleeson JG. Homozygous mutation in NUP107 leads to microcephaly with steroid-resistant nephrotic condition similar to Galloway-Mowat syndrome. J Med Genet. 2017 Jun;54(6):399-403. doi: 10.1136/jmedgenet-2016-104237.
  27. Taşdemir M. Metabolic abnormalities in children with urinary stone disease and the influence of gender Med Bull Sisli Etfal Hosp 2017, 51(3):218-224. doi: 10.5350/SEMB.20170417014107
  28. Erol M, Bostan Gayret O, Tekin Nacaroglu H, Yigit O, Zengi O, Salih Akkurt M, Tasdemir M. Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children. Iran Red Crescent Med J. 2016 Nov 1;18(11):e41873. doi: 10.5812/ircmj.41873.
  29. Taşdemir M, Hasan C, Ağbaş A, Kasapçopur Ö, Canpolat N, Sever L, Çalışkan S. Sjögren's syndrome associated with systemic lupus erythematosus. Turk Pediatri Ars. 2016 Sep 1;51(3):166-168.
  30. Erol M, Yigit O, Tasdemir M, Bostan Gayret O, Buke O, Gunes A, Hamilcikan S, Kasapcopur O. Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura. Iran J Pediatr. 2016 Jun 5;26(4):e6129.
  31. Nacaroglu T, Gayret OB, Erol M, Buke O, Zengi O, Tasdemir M, Tasdemir Z, Yigit O. Biomarkers of airway and systemic inflammation in obese asthmatic pediatric patients. Allergologia et Immunopathologia
  32. Taşdemir M, Fuçucuoğlu D, Özman O, Sever L, Önal B, Bilge I. Silicate calculi, a rare cause of kidney stones in children. Pediatr Nephrol. 2017 Feb;32(2):371-374. doi: 10.1007/s00467-016-3504-4.
  33. Taşdemir M, Eroğlu AG, Canpolat N, Konukoğlu D, Ağbaş A, Sevim MD, Çalışkan S, Sever L. Cardiovascular alterations do exist in children with stage-2 chronic kidney disease. Clin Exp Nephrol. 2016 Dec;20(6):926-933.
  34. Nacaroglu HT, Yavuz S, Basman E, Bahceci S, Tasdemir M, Yigit Ö, Can D. The clinical spectrum of reactions developed based on paraphenylenediamine hypersensitivity two pediatric cases. Postepy Dermatol Alergol. 2015 Oct;32(5):393-5. doi: 10.5114/pdia.2015.52738.
  35. Candan C, Canpolat N, Gökalp S, Yıldız N, Turhan P, Taşdemir M, Sever L, Çalışkan S. Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2014 Jan;29(1):95-102. doi: 10.1007/s00467-013-2608-3.
  36. Canpolat N, Caliskan S, Sever L, Tasdemir M, Ekmekci OB, Pehlivan G, Shroff R. Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis. Pediatr Nephrol. 2013 Nov;28(11):2149-56. doi:10.1007/s00467-013-2527-3.
  37. Onal B, Dogan C, Citgez S, Argun B, Onder AU, Sever L, Caliskan S, Canpolat N, Tasdemir M, Erozenci A. Percutaneous nephrolithotomy in children with cystine stone: long-term outcomes from a single institution. J Urol. 2013 Jul;190(1):234-7. doi: 10.1016/j.juro.2013.01.016.
  38. Canpolat N, Kasapcopur O, Caliskan S, Gokalp S, Bor M, Tasdemir M, Sever L, Arisoy N. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol. 2013 Feb;28(2):305-13. doi: 10.1007/s00467-012-2317-3. PubMed PMID: 23052654.
  39. Tasdemir M, Canpolat N, Uludag D, Sener D, Arisoy N. Henoch-Schöenlein purpura associated with Mycoplasma pneumoniae. Turk Pediatri Ars. 2011, 46(4):354-355.
  40. Girgin D, Dalgıc N, Telhan L, Kafadar I, Tasdemir M, Sahin S, Caglar A, Hasim O. Systemic capillary leak syndrome associated with pleural effusion. Turk Pediatri Ars. 2010, 45:61-63.
  41. Tasdemir M, Karakoc F. Phenotypes of Asthma. Turkiye Klinikleri J Pediatr Sci 2009, 5(3):36-40
  42. Bulbul A, Tasdemir M, Pullu M, Okan F, Bulbul L, Nuhoglu A. Nosocomial infection in the neonatal intensive care unit. Med Bull Sisli Etfal Hosp 2009, 43(1), 27-32.
  43. Telhan L, Erdem E, Tasdemir M, Sakız D, Arapoglu M, Palanduz A. A fatal case of mucormycosis. J Pediatr Inf 2007, 1:118-120.